References
- Boutet R, Stuart JM, Kaczmarski EB, Gray SJ, Jones DM, Andrews N. Risk of laboratory-acquired meningococcal disease. J Hosp Inf 2001; 49: 282–4
- Sejvar JJ, Johnson D, Popovic T, Miller M, Downes F, Somsel P, et al. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol 2005; 43: 4811–4
- Mölling P, Jacobsson S, Bäckman A, Olcén P. Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR. J Clin Microbiol 2002; 40: 4531–5
- Weis N, Berthelsen L, Wachmann H, Lind I. The meningococcal antibody test: how useful in the diagnosis of meningococcal disease?. Epidemiol Infect 2004; 133: 217–27
- Thulin S, Olcén P, Fredlund H, Unemo M. Total variation in the penA gene of Neisseria meningitides: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob Agents Chemother 2006; 50: 3317–24
- Apicella MA. Neisseria meningitidis. Principles and Practice of Infectious Diseases6th edn, GL Mandell, JE Bennet, Dolin. Churchill Livingstone, Philadelphia, Pennsylvania 2005; 2499–506
- Gilkman D, Scott M, Matushek MS, Madelym D K, Robert S D. Pneumonia and empyema caused by penicillin-resistant Neisseria meningitidis: a case report and literature review. Pediatrics 2006; 117: 1061–6
- Taha MK, Alonso JM, Cafferkey M, Caugant DA, Clarke SC, Diggle MA, et al. Interlaboratory comparison of PCR-based identification and genotyping of Neisseria meningitidis. J Clin Microbiol 2005; 43: 144–9
- Taha MK, Olcén P. Molecular genetic methods in diagnosis and direct characterization of acute bacterial central nervous system infections. APMIS 2004; 112: 753–70